Shares of Emergent BioSolutions Inc. rallied about 19% in premarket trading on Thursday, the day after a Food and Drug Administration advisory committee...
Shares of Emergent BioSolutions Inc. EBS rallied about 19% in premarket trading on Thursday, the day after a Food and Drug Administration advisory committee voted in favor of allowing over-the-counter sales of Narcan, the opioid overdose reversal medication. The FDA is not required to follow the advice of the committee but often does.
... Shares of Emergent BioSolutions Inc. EBS rallied about 19% in premarket trading on Thursday, the day after a Food and Drug Administration advisory committee voted in favor of allowing over-the-counter sales of Narcan, the opioid overdose reversal medication. The FDA is not required to follow the advice of the committee but often does.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA Panel Backs Moving Opioid Antidote Narcan Over the CounterU.S. health advisers say the overdose-reversal drug naloxone should be made available as an over-the-counter medication. It’s the latest government proposal to increase use of the medication against the opioid overdose crisis. The nasal spray version, Narcan, is already available without a prescription in all 50 states. But switching it to over-the-counter status would allow it to be sold in vending machines, supermarkets and other locations. The positive vote by an Food and Drug Administration advisory panel came despite difficulties understanding how to use the drug in a company study. FDA will make a final decision on the drug in coming weeks.
Read more »
FDA panel backs moving opioid antidote Narcan over the counterThe nasal spray version, Narcan, is already available without a prescription in all 50 states. But switching it to over-the-counter status would allow it to be sold in vending machines, supermarkets and other locations.
Read more »
FDA panel says opioid antidote Narcan should be available over the counterThe overdose-reversal drug naloxone should be available as an over-the-counter medication to aid the national response to the opioid crisis, U.S. health...
Read more »
FDA panel backs moving opioid antidote Narcan over the counterThe nasal spray version, Narcan, is already available without a prescription in all 50 states. But switching it to over-the-counter status would allow it to be sold in vending machines, supermarkets and other locations.
Read more »
FDA panel: Narcan spray shouldn't need a prescriptionFood and Drug Administration advisers on Wednesday unanimously declared Narcan, a nasal spray antidote for opioid overdoses, safe for over-the-counter use, effectively pushing the agency closer to approving it for national distribution.
Read more »
Opioid antidote Narcan should be available over the counter, FDA panel saysA panel urged the FDA to give final approval to a plan that would make Narcan, the nasal version of the overdose-reversal drug naloxone, available over the counter.
Read more »